- Home
- RLMD vs CRIS Comparison
RLMD vs CRIS Comparison
Compare RLMD & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- CRIS
- Stock Information
- Founded
- RLMD 2004
- CRIS 2000
- Country
- RLMD United States
- CRIS United States
- Employees
- RLMD N/A
- CRIS N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RLMD Health Care
- CRIS Health Care
- Exchange
- RLMD Nasdaq
- CRIS Nasdaq
- Market Cap
- RLMD 22.0M
- CRIS 21.3M
- IPO Year
- RLMD N/A
- CRIS 2000
- Fundamental
- Price
- RLMD $0.61
- CRIS $1.81
- Analyst Decision
- RLMD Buy
- CRIS Strong Buy
- Analyst Count
- RLMD 3
- CRIS 2
- Target Price
- RLMD $5.00
- CRIS $16.50
- AVG Volume (30 Days)
- RLMD 338.9K
- CRIS 163.8K
- Earning Date
- RLMD 08-06-2025
- CRIS 07-31-2025
- Dividend Yield
- RLMD N/A
- CRIS N/A
- EPS Growth
- RLMD N/A
- CRIS N/A
- EPS
- RLMD N/A
- CRIS N/A
- Revenue
- RLMD N/A
- CRIS $11,202,000.00
- Revenue This Year
- RLMD N/A
- CRIS N/A
- Revenue Next Year
- RLMD N/A
- CRIS $10.67
- P/E Ratio
- RLMD N/A
- CRIS N/A
- Revenue Growth
- RLMD N/A
- CRIS 14.17
- 52 Week Low
- RLMD $0.24
- CRIS $1.02
- 52 Week High
- RLMD $4.47
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- RLMD 47.74
- CRIS 43.58
- Support Level
- RLMD $0.60
- CRIS $1.50
- Resistance Level
- RLMD $0.69
- CRIS $1.98
- Average True Range (ATR)
- RLMD 0.07
- CRIS 0.19
- MACD
- RLMD -0.01
- CRIS -0.05
- Stochastic Oscillator
- RLMD 41.86
- CRIS 43.88
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.